Results 121 to 130 of about 1,275,522 (345)

Phenotypic and genotypic characterization of single circulating tumor cells in the follow‐up of high‐grade serous ovarian cancer

open access: yesMolecular Oncology, EarlyView.
Single circulating tumor cells (sCTCs) from high‐grade serous ovarian cancer patients were enriched, imaged, and genomically profiled using WGA and NGS at different time points during treatment. sCTCs revealed enrichment of alterations in Chromosomes 2, 7, and 12 as well as persistent or emerging oncogenic CNAs, supporting sCTC identity.
Carolin Salmon   +9 more
wiley   +1 more source

UNLOCKING BUSINESS GROWTH IN EAST JAVA'S SMES: THE SYNERGY OF KNOWLEDGE MANAGEMENT AND DYNAMIC CAPABILITIES FUELING INNOVATION AMBIDEXTERITY

open access: yesJurnal Ekonomi Bisnis dan Kewirausahaan (JEBIK)
This research seeks to delve into the role of Knowledge Management Capability (KMC), Dynamic Capability (DC), and Ambidexterity Innovation (IA) in fostering Business Performance (BP) amongst Micro, Small, and Medium Enterprises (MSMEs) in the province of
Edlyn Khurotul Aini   +1 more
doaj   +1 more source

Dynamic Objects Segmentation for Visual Localization in Urban Environments

open access: yes, 2018
Visual localization and mapping is a crucial capability to address many challenges in mobile robotics. It constitutes a robust, accurate and cost-effective approach for local and global pose estimation within prior maps.
Bescos, Berta   +5 more
core   +1 more source

Business models and dynamic capabilities

open access: yesLong Range Planning, 2018
Abstract Business models, dynamic capabilities, and strategy are interdependent. The strength of a firm's dynamic capabilities help shape its proficiency at business model design. Through its effect on organization design, a business model influences the firm's dynamic capabilities and places bounds on the feasibility of particular strategies.
openaire   +3 more sources

TRAIL‐PEG‐Apt‐PLGA nanosystem as an aptamer‐targeted drug delivery system potential for triple‐negative breast cancer therapy using in vivo mouse model

open access: yesMolecular Oncology, EarlyView.
Aptamers are used both therapeutically and as targeting agents in cancer treatment. We developed an aptamer‐targeted PLGA–TRAIL nanosystem that exhibited superior therapeutic efficacy in NOD/SCID breast cancer models. This nanosystem represents a novel biotechnological drug candidate for suppressing resistance development in breast cancer.
Gulen Melike Demirbolat   +8 more
wiley   +1 more source

Firms' transition towards green product service system innovators [PDF]

open access: yes
Within this paper we explore transition paths firms can take to become product service system (PSS) innovators. Applying the dynamic capability approach we study how three firms have developed PSS innovations in the mobility sector (Car2Go by Daimler AG,
Herstatt, Cornelius   +2 more
core  

Tumour–host interactions in Drosophila: mechanisms in the tumour micro‐ and macroenvironment

open access: yesMolecular Oncology, EarlyView.
This review examines how tumour–host crosstalk takes place at multiple levels of biological organisation, from local cell competition and immune crosstalk to organism‐wide metabolic and physiological collapse. Here, we integrate findings from Drosophila melanogaster studies that reveal conserved mechanisms through which tumours hijack host systems to ...
José Teles‐Reis, Tor Erik Rusten
wiley   +1 more source

Home - About - Disclaimer - Privacy